Since 2008, here at Philip Morris International, we’ve invested more than USD 10.5 billion into the science and research of developing smoke-free products, and we employ more than 1,516 world-class scientists, engineers, and technicians to help us.
When it comes to science and research, we set ourselves high standards, and our scientific methods are inspired by the pharmaceutical industry. We share our scientific findings publicly and encourage others to review our work. Our vision is to offer current adult smokers a better choice than continued smoking. How are we making this vision a reality? By developing a portfolio of smoke-free products that deliver nicotine without burning tobacco and which current adult smokers find satisfying.